Non-Hodgkin Lymphoma Trials

Click on one of the links below to view information about the relevant non-Hodgkin lymphoma clinical trial. You will also have the option to download a print-friendly pdf version of the information pages.

• Treatment Every 2 Weeks or Every 3 Weeks for Non-Hodgkin Lymphoma (r-CHOP 14 versus r-CHOP 21)
• Watch and Wait. Rituximab Versus a Watch and Wait Strategy in People With Advanced Stage, Asymptomatic, Non-Bulky Follicular Lymphoma
• Fludarabine and Cyclophosphamide With or Without Rituximab for Newly Diagnosed Mantle Cell Lymphoma
• Chemotherapy and Rituximab for Diffuse Large B-Cell Non-Hodgkin Lymphoma (Collaborative Trial in Relapsed Aggressive Lymphoma - CORAL)
• FORT (Follicular Radiotherapy Trial)